RCPE GmbH RCPE GmbH May 2010 K1 Competence Center - Initiated by the Federal Ministry of Economy, Family and Youth (BMWFJ) and the Federal Ministry of Transport, Innovation and Technology (BMVIT). Funded by FFG, Land Steiermark and Steirische Wirtschaftsförderung (SFG). L
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
RCPE GmbHRCPE GmbHMay 2010
K1 Competence Center - Initiated by the Federal Ministry of Economy, Family and Youth (BMWFJ) and the Federal Ministry of Transport, Innovation and Technology (BMVIT). Funded by FFG, Land Steiermark and Steirische Wirtschaftsförderung (SFG).
L
RCPE - KEY FACTS 1/2
Competence Centers are highly successful technology policy initiatives in Austria (currently 40+ centers with 1500+ researchers)Obj ti f C t C tObjectives of Competence Centers:
Cooperation between science and industryA hi i j i t t t i t l l hAchieving joint strategic top-level research Initiate new scientific and technological developments
Ne Competence Center la nched on the 1st of J l 2008New Competence Center launched on the 1st of July 2008: Research Center Pharmaceutical Engineering GmbH (RCPE) Total volume: approx €30 Mio ($42 Mio) for 7 yearsTotal volume: approx. €30 Mio ($42 Mio) for 7 yearsTimeframe: 7 years (extension possible)L t d i G A t iLocated in Graz, Austria
RCPE - KEY FACTS 2/2
RCPE is a non-profit limited liability company (GmbH)
100% owned by research institutions (Graz University of Technology: 65%, University of Graz: 20%, Joanneum Research: 15%)
RCPE projects are partially funded by the Austrian Research PromotionRCPE projects are partially funded by the Austrian Research Promotion Agency (national funding institution for applied industrial research in Austria) with 32.67% and by the province of Styria with 16.33%
Total public financing of 49%
min 26% cash5% i tifi
Joanneum Research: 15%
University of Graz: 20%min. 26% cash5% scientific
max. 20% in-kind
49% fundings
in kind
Graz University of Technology: 65%
Project funding overview Ownership structure
RCPE - KEY BENEFITS
RCPE provides independent R&D in the field of pharmaceutical i i b id i th b t i d i d t i l li tiengineering, bridging the gap between science and industrial applications
Defined IPRs provide maximum benefit for industrial partners
Long term cooperation with the RCPE possibleLong-term cooperation with the RCPE possible (funding period of 7+ years)
Diversity in research activities: small preparatory studies (literature review, initial measurements, proof of concept) up to extensive multi-year research programs are possible
Only 26% cash contribution required in joint research projectsOnly 26% cash contribution required in joint research projects
No time-consuming project application procedures; project work plan can be defined bilaterally and the project can be started immediately
RCPE can provide additional scientific partners if expertise is required
RCPE can provide additional industrial partners if industrial cooperation i d i d d/ f j t t h iis desired and/or for project cost-sharing
RCPE - TOPICS
We are interested to add YOU as Company or Scientific Partnerf ki t th th f ll i t ifor working together on the following topics:
Simulation toolsParticle technology (Coating, extrusion, melt extrusion, drying, etc.)Bioprocessing and bioreactorsPrinting of drugsPrinting of drugsProcess Analytical Technology (PAT)Continuous processingProtein manufactureMicroparticle synthesisQuality by Design (QbD)Quality by Design (QbD)
New areas and topics are welcome
RCPE - AREAS OF THE CENTER
AREA I –SELECTION OF CURRENT PROJECTSSELECTION OF CURRENT PROJECTS
Softwares: FIRE OpenFOAM Software: MOESoftwares: FIRE, OpenFOAM Software: MOE
OVERALL RCPE BUDGET AND FUNDING
16,7 Mio.€f ffor four years
Scientific
Partners 46%
Partners
5%
16 33%
Province of Styria
Funding 54%
16,33%
54%
32,67%,
IPRS AND FUNDING MODEL
Defined IPRsFull IPR to industry partners
Gratuitous non exclusive timely unlimited non transferableDefined IPRs(Intellectual Properties Rights)
Gratuitous, non-exclusive, timely unlimited non-transferable right of use to RCPE
Exploitation and utilization rights to RCPE after 12-24 months
Project Financing (Example)
Details must be singularly clarified in cooperation contract
P j t V l € 500 000Project Volume € 500.000,-
Funding 49% € 245.000,-
Inkind University 5% € 25.000,-
min. 26% cash5% scientific
max. 20% in kind
Cash Industry 26% min. € 130.000,-
Inkind Industry 20% max. € 100.000,-49% fundings
in-kind
3 Industry Partners:Cash per each industry partner € 43.333,-
Inkind per each partner € 33 333 -
2 Industry Partners:Cash per each industry partner € 65.000,-
Inkind per each partner € 50 000 - Inkind per each partner € 33.333,Inkind per each partner € 50.000,
SUCCESS STORY
RCPE was founded on 1st of July 2008app. 65 employees3 new Scientific Partners and 18 new Industrial Partners4 patents
A t f l i l t f d i h ti l d tA system for analyzing a granulate for producing a pharmaceutical productA system and method for manufacturing a medicationMethods and compositions for biologically controlling microbial growth on l i tclean room equipment
Synthetical Nucleic-Acid-ParticleWorking Group at Rutgers University in New Jersey, USA established (since 15th of April 2009, three employees)One new Business Unit (RCPS) has been launched
THE PROCESS ENGINEERING CENTER
Office building with state-of-the-art laboratory facilitiesStart of construction: 2009Scheduled for completion: 2011Footprint: 1000 m² / 7 stories + basementp